Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.
Corral J, Hernandez-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, Perez-Ceballos E, Lecumberri R, Sanchez I, Roldan V, Mateo J, Minano A, Gonzalez M, Alberca I, Fontcuberta J, Vicente V. Corral J, et al. Blood. 2007 May 15;109(10):4258-63. doi: 10.1182/blood-2006-08-040774. Epub 2007 Jan 23. Blood. 2007. PMID: 17244682 Free article.
Latent and polymeric antithrombin: clearance and potential thrombotic risk.
Corral J, Rivera J, Guerrero JA, Miñano A, Alberca I, Hernández-Espinosa D, Ordóñez A, Martínez C, Navarro-Núñez L, González-Conejero R, Lozano ML, Vicente V. Corral J, et al. Exp Biol Med (Maywood). 2007 Feb;232(2):219-26. Exp Biol Med (Maywood). 2007. PMID: 17259329
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.
Hernández-Espinosa D, Miñano A, Martínez C, Ordoñez A, Pérez-Ceballos E, de Arriba F, Mota RA, Ferrer F, González M, Vicente V, Corral J. Hernández-Espinosa D, et al. Lab Invest. 2008 Mar;88(3):306-17. doi: 10.1038/labinvest.3700717. Epub 2008 Jan 14. Lab Invest. 2008. PMID: 18195690 Free article. Clinical Trial.
39 results